LY3143753

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3143753, covering 2019-03-13 to 2019-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3143753 and LY3185643 in Healthy Participants [Phase 1]